The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Bloodstream Infection Testing-Global Market Insights and Sales Trends 2024
Synopsis
The global Bloodstream Infection Testing market size is expected to reach US$ 1441.6 million by 2029, growing at a CAGR of 5.1% from 2023 to 2029. The market is mainly driven by the significant applications of Bloodstream Infection Testing in various end use industries. The expanding demands from the Hospital, Clinic, Medical Center and Other, are propelling Bloodstream Infection Testing market. Medical Equipment, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Detection Reagent segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bloodstream Infection Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bloodstream Infection Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bloodstream Infection Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bloodstream Infection Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bloodstream Infection Testing covered in this report include Abbott, BD, bioMerieux, Danaher, F. Hoffmann-La Roche and Thermo Fisher Scientific, etc.
The global Bloodstream Infection Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
BD
bioMerieux
Danaher
F. Hoffmann-La Roche
Thermo Fisher Scientific
Global Bloodstream Infection Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bloodstream Infection Testing market, Segment by Type:
Medical Equipment
Detection Reagent
Global Bloodstream Infection Testing market, by Application
Hospital
Clinic
Medical Center
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bloodstream Infection Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Bloodstream Infection Testing market size is expected to reach US$ 1441.6 million by 2029, growing at a CAGR of 5.1% from 2023 to 2029. The market is mainly driven by the significant applications of Bloodstream Infection Testing in various end use industries. The expanding demands from the Hospital, Clinic, Medical Center and Other, are propelling Bloodstream Infection Testing market. Medical Equipment, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Detection Reagent segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bloodstream Infection Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bloodstream Infection Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bloodstream Infection Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bloodstream Infection Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bloodstream Infection Testing covered in this report include Abbott, BD, bioMerieux, Danaher, F. Hoffmann-La Roche and Thermo Fisher Scientific, etc.
The global Bloodstream Infection Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
BD
bioMerieux
Danaher
F. Hoffmann-La Roche
Thermo Fisher Scientific
Global Bloodstream Infection Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bloodstream Infection Testing market, Segment by Type:
Medical Equipment
Detection Reagent
Global Bloodstream Infection Testing market, by Application
Hospital
Clinic
Medical Center
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bloodstream Infection Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Bloodstream Infection Testing
1.1 Bloodstream Infection Testing Market Overview
1.1.1 Bloodstream Infection Testing Product Scope
1.1.2 Bloodstream Infection Testing Market Status and Outlook
1.2 Global Bloodstream Infection Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Bloodstream Infection Testing Market Size by Region (2018-2029)
1.4 Global Bloodstream Infection Testing Historic Market Size by Region (2018-2023)
1.5 Global Bloodstream Infection Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Bloodstream Infection Testing Market Size (2018-2029)
1.6.1 North America Bloodstream Infection Testing Market Size (2018-2029)
1.6.2 Europe Bloodstream Infection Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Bloodstream Infection Testing Market Size (2018-2029)
1.6.4 Latin America Bloodstream Infection Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Bloodstream Infection Testing Market Size (2018-2029)
2 Bloodstream Infection Testing Market by Type
2.1 Introduction
2.1.1 Medical Equipment
2.1.2 Detection Reagent
2.2 Global Bloodstream Infection Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Bloodstream Infection Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Bloodstream Infection Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Bloodstream Infection Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Bloodstream Infection Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Bloodstream Infection Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Bloodstream Infection Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Bloodstream Infection Testing Revenue Breakdown by Type (2018-2029)
3 Bloodstream Infection Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Medical Center
3.1.4 Other
3.2 Global Bloodstream Infection Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Bloodstream Infection Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Bloodstream Infection Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Bloodstream Infection Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Bloodstream Infection Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Bloodstream Infection Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Bloodstream Infection Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Bloodstream Infection Testing Revenue Breakdown by Application (2018-2029)
4 Bloodstream Infection Testing Competition Analysis by Players
4.1 Global Bloodstream Infection Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bloodstream Infection Testing as of 2022)
4.3 Date of Key Players Enter into Bloodstream Infection Testing Market
4.4 Global Top Players Bloodstream Infection Testing Headquarters and Area Served
4.5 Key Players Bloodstream Infection Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Bloodstream Infection Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Bloodstream Infection Testing Products, Services and Solutions
5.1.4 Abbott Bloodstream Infection Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 BD
5.2.1 BD Profile
5.2.2 BD Main Business
5.2.3 BD Bloodstream Infection Testing Products, Services and Solutions
5.2.4 BD Bloodstream Infection Testing Revenue (US$ Million) & (2018-2023)
5.2.5 BD Recent Developments
5.3 bioMerieux
5.3.1 bioMerieux Profile
5.3.2 bioMerieux Main Business
5.3.3 bioMerieux Bloodstream Infection Testing Products, Services and Solutions
5.3.4 bioMerieux Bloodstream Infection Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Danaher Recent Developments
5.4 Danaher
5.4.1 Danaher Profile
5.4.2 Danaher Main Business
5.4.3 Danaher Bloodstream Infection Testing Products, Services and Solutions
5.4.4 Danaher Bloodstream Infection Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Danaher Recent Developments
5.5 F. Hoffmann-La Roche
5.5.1 F. Hoffmann-La Roche Profile
5.5.2 F. Hoffmann-La Roche Main Business
5.5.3 F. Hoffmann-La Roche Bloodstream Infection Testing Products, Services and Solutions
5.5.4 F. Hoffmann-La Roche Bloodstream Infection Testing Revenue (US$ Million) & (2018-2023)
5.5.5 F. Hoffmann-La Roche Recent Developments
5.6 Thermo Fisher Scientific
5.6.1 Thermo Fisher Scientific Profile
5.6.2 Thermo Fisher Scientific Main Business
5.6.3 Thermo Fisher Scientific Bloodstream Infection Testing Products, Services and Solutions
5.6.4 Thermo Fisher Scientific Bloodstream Infection Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Thermo Fisher Scientific Recent Developments
6 North America
6.1 North America Bloodstream Infection Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Bloodstream Infection Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Bloodstream Infection Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Bloodstream Infection Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Bloodstream Infection Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Bloodstream Infection Testing Market Dynamics
11.1 Bloodstream Infection Testing Industry Trends
11.2 Bloodstream Infection Testing Market Drivers
11.3 Bloodstream Infection Testing Market Challenges
11.4 Bloodstream Infection Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
